Federal District Court Judge Rodney Sippel has ordered Organon BioSciences USA, a subsidiary of Merck & Co., to release safety information on NuvaRing that manufacturers had tried to keep out of court. Only time will tell how that ruling – and what’s contained in these confidential documents – will affect the 1,000 NuvaRing injury lawsuits currently pending in multi-district litigation (MDL).

What’s In These “Secret” NuvaRing Documents?

Organon had filed several motions seeking to keep certain NuvaRing documents off-limits to plaintiffs’ lawyers – saying that they contained confidential and/or proprietary information that, if released, could damage the company’s reputation. Judge Sippel eventually ruled against Organon and reasoned that the public had a right to their access.

So, what’s in these “secret” NuvaRing documents? According to court records, the documents contain expert motions, memoranda and depositions that are not favorable to the defendants such as:

• An expert pharmacological report which shows that Organon concealed or misrepresented safety data to doctors and the U.S. Food & Drug Administration (FDA);
• Documents reporting that two women participating in a NuvaRing study early on had to drop out of that study because their estrogen levels were dangerously high.

While this type of information could certainly damage the pharmaceutical giant’s reputation, it may very well help the injured victims who have suffered a deep vein thrombosis, heart attack, stroke, gallbladder disease, breast cancer or other dangerous NuvaRing side effects.

FDA & Medical Studies Detail NuvaRing Increased Risk Of Injury

Numerous studies have shown that NuvaRing usage carries very high risks for injury. The FDA, which has received thousands of adverse event reports which link NuvaRing to blood clot injuries, reported that women who used NuvaRing had a 56% increased risk of suffering a blood clot than women who used traditional birth control pills.

In addition, the British Medical Journal published a study last year which reported that women using NuvaRing had a 90% greater chance of suffering a venous thromboembolism (VTE), another name for the clotting of a blood vessel, and concluded that women were much safer taking birth control pills.

There is clearly a great deal of controversy surrounding the safety of NuvaRing. Just ask the thousands of women who have been injured. If you’re in that group, it’s important to know that you do have options. Call The Driscoll Firm, LLC, to discuss those options and determine whether filing a NuvaRing injury lawsuit is in your best interests.